Abel, G. & J. K. Czop. (1992) Int. J. Immunopharmarc. 14 (8): 1363-1373 Stimulations of Human Monocyte B-Glucan Receptors by Glucan particles Induces Production of TNF-a and IL-1B

Abrams, D., Wong, R., Greco, M., Goosby, E., Garter, R., Gordon, M., Guralnik, M. and Y. Kaneko. Results of a Phase I/II Placebo-Controlled Dose-Finding Pilot Study of Lentinan in Patients with HIV Infection. Sixth International Conference on AIDS, San Francisco, (June 20-24, 1990).

Aoki, T., Miyakoshi, H., Horikawa, Y. and Y. Usuda. Staphage lysate and Lentinan as immunomodulators and/or immunopotentiators in clinic and experimental systems. In: Augmenting Agents in Cancer Therapy, Hersh, E. M. et al (Ed), Raven Press, New York, pp 101-112 (1981).

Browder W, Sherwood E, Williams D, Jones E, Mc Namee R, Di Luzio N, Am J Surg (1987) 199: 25-33 Protective effect of Glucan-Enhanced Macrophage Function in Experimental Pancreatitis.

Cleary JA, Kelli GE, Husband AJ, Immunol and Cell Biol (1999)77:395-403 The effect of molecular weight and Beta 1,6 Linkages on priming of macrophage function in mice by (1,3)-Beta- D-Glucan.

Czop JK, Valiante NM,janusz MJ, Biochemestry of the Acute Allergic Reactions: Fifth Intern Symp: 287-296 Phagocytosis of Particulatre Activators of the Human Alternative Complement Pathway Through Monocyte Beta -Glucan Receptors.

Chihara, G. , Hamuro, J., Maeda, Y.Y., Arai, Y & Fukuoka, F. (1987) Function and purification of the polysaccharides with marked antitumor activity, especially Lentinan, from Lentinus edodes (Berk.) Cancer Res., 30, 2776-2781.

Chihara G; (Teiko University, Kawasaki Japan): recent progress in immunopharmacology and therapeutic effects of polysaccharides. Dev. Biol. Stand. 1992; 77:191-7).

Chihara, G., Maeda, Y., Hamuro, J., Sasaki, T. and F. Fukuoka. Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes. Nature 222, pp 637-638 (1969).

Coca, A.F. (1914). Zeit. Immunitätsforsch. 21: 604

Di Renzo, L., Yefenot E., Klein," E: "The Function of Human NK cells is enhanced by B-Glucan, a ligand of CR3 (CDI lb/CDI 8)." Euro. J. Immunol., 21:1755-1758; 1991.

Falch BH, Espevik T, Ryan L, Stokke BT.The cytokine stimulating activity of (1-->3)-beta-D-glucans is dependent on the triple helix conformation.Carbohydr Res. 2000 Nov 17;329(3):587-96.
PMID: 11128587 [PubMed - indexed for MEDLINE]

Fizpatrick, F.W. & F.J. DiCarlo. (1964). Ann. N. J. Acad. Sci. 118: 233

Jorgensen B, Robertsen B, Dev Comp Immunol 19: 43-57 (1995) Yeast Beta Glucan Stimulates Respiratory Burst Activity of Atlantic Salmon (Salmo salar L.) Macrophages.

Kokoshis PL, Williams DL, Cook JA, Di Luzio NR, Science (1978) 199: 1340-1342 Increased Resistance to Staphilococcus aureus Infection and Enhancement in Serum Lysozyme Activity by Glucan.

Kasai, S., Fujimoto, S., Nitta, K., Baba, H., Kunimoto, T.: "Antitumor activity of polymorphonuclear leukcytes activated by a B-1,3-D-glucan." J. Pharmacobiodyn, 14:519-525; Medline

Hamuro, J. and G. Chihara, G. Chapter 19, Lentinan, a T-cell oriented immunopotentiator. In: Modulation Agents and their Mechanisms; Fenichel, R.L. (Ed); Marcel Dekker, Inc., New York and Basel, pp 409-436 (1984)

Ohno N. [Modulation of host defense systems by beta-glucans].
Nippon Saikingaku Zasshi. 2000 Aug;55(3):527-37. Review. Japanese. No abstract available.
PMID: 11021088 [PubMed - indexed for MEDLINE]

Onifade A, Nahrung 41: 370-374 (1997) Growth performance, carcass characteristics, organs measurement and hematology of broiler chikens fed a high fibre diet supplemented with antibiotics or dried yeast.

Pangburn, M. K. and G. D. Ross. The complement system. In Dulbecco, R., ed. Encyclopedia of Human Biology. San Diego, CA, Academic Press, Inc. 1997, 945-962.

Patchen ML, Mac Vittie TJ, J Biool Response Mod 5:45-60 (1886) Raven Press NY Comparative effects of Soluble and Particulate Glucans on Survival in Irradiated Mice.

Patchen, M. L.: D'Alesandro M. M., Brook, I., Blakely, W. F., McVittie, T. J.: "Glucan: Mechanisms Involved in Its Radioprotective Effect." J. Leuc. Biol., 42:95-105; 1987

Paulik, S., Svrcek, S., et al: "The effect of fungal and yeast glucan and levamisole on the level of the cellular immune response in vivo and leukocyte phagocytic activity in mice," Vet Med (Praha) 37: 675-685. 1992.

Pillemer, L. & E.E. Echer. (1941). J. Biol. Chem. 137: 139

Ross, D., Van Schaik, M.L.F., de Boer, M., Daha M.R.: "Interaction between neutrophils and zymosan particles: the role of opsonin and divalent cations;" J. Immunol. 126:433; 1981.

Ross, G. D., Cain, J.A., Myones B.L. et al: "Specificity of membrane complement receptor type three (CR3) for beta-glucans," Complement 4:61-74; 1987.

Ross, G. D., V. Vetvicka, and B. P. Thornton. Analysis of the phagocyte membrane lectin CR3 (CD11b/CD18) using fluorescence-labeled polysaccharides and flow cytometry. In Robinson, J. P. and G. F. Babcock, eds. Phagocyte Functions: A Guide for Research and Clinical Evaluation. New York, John Wiley & Sons, Inc. 1998, 1-17.

Ross, G. D., V. Vetvicka, J. Yan, Y. Xia, and J. Vetvicková. Therapeutic intervention with complement and b-glucan in cancer. Immunopharmacology 42: 61-74, 1999.

Shandula, I., Kogan, G., Masler, L.: "Structure and various characteristics of yeast beta-D-glucans," Vopr Med Khim 36:39-42; 1990.

Sherwood, E. R., et al: "Enhancement of Interleukin-I and Interleucan-2 Production by Soluble Glucan," International Journal of Immunopharmacology., 9:(3):261-267; 1987

Song Yl, Liu JJ, Chan LC, Sung HH, Fish Vacc Dev Biol Stand (1997) 90: 4213-421 Glucan -Induced Disease Resistance in Tiger Shrimp(Penaeus monodon).

Suzuki, T., Ohno, N., et al: "Activation of the complement system by (1-3)-beta-D-glucans having different degrees of branching and different ultrastractures," J. Pharmacobiodyn 15:277-285; 1992

Tapper, H., Sundier, R.: "Glucan receptor and zymosan-induced lysosomal enzyme secretion in macrophages," Biochem. J. 306:829-835; 1995.

Thornton, B. P., V. Vetvicka, M. Pitman, R. C. Goldman, and G. D. Ross. Analysis of the sugar specificity and molecular location of the b-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156: 1235-1246, 1996.

Von Dungern, E. (1900). Munch. Med. Woch. 47: 677

Vetvicka V., Thornton, B. P., Ross, G. D.: "Soluble Beta-glucan Polysacchazide Binding to the Lectin Site of Neutrophil or Natural Killer Cell Complement Receptor Type 3 (CD11b/CD18) Generates a Primed State of the Receptor Capable of Mediating Cytotoxicity of iC3b-Opsonized Target Cells,". Journal Clin. Invest. 98:50-61; 1996. Div. of Experimental Immuno. and Immunopath., Dept. Path., Univ. of Louisville, KY.

Vetvicka, V., B. P. Thornton, T. J. Wieman, and G. D. Ross. Targeting of NK cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and b-glucan-primed CR3 (CD11b/CD18). J. Immunol. 159: 599-605, 1997.

Vetvicka, V., M. Hanikyrova, J. Vetvicková, and G. D. Ross. Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules. Clin. Exp. Immunol. 115: 229-235, 1999.

Yan, J., V. Vetvicka, Y. Xia, A. Coxon, M. C. Carroll, T. N. Mayadas, and G. D. Ross. b-Glucan, a "specific" biologic response modifier that uses antibodies to target tumors for recognition by complement receptor type 3 (CD11b/CD18). J. Immunol. 163: 3045-3052, 1999.

Yan, J., V. Vetvicka, Y. Xia, M. Hanikyrova, T. N. Mayadas, and G. D. Ross. Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble b-glucan. Immunopharmacology 46: 39-54, 2000.

Whitehead, H.R., J. Gordon& A. Wormall (1925). Biochem. J. 19: 618